BeiGene, Ltd. Contracts & Agreements

Offer Letter (Filed With SEC on August 7, 2024)

Separation and Transition Agreement, dated July 17, 2024, by and between the Registrant and Julia Wang (Filed With SEC on August 7, 2024)

Form of Global Performance Share Unit Award Agreement for Employees under the Third Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 7, 2024)

Form of Global Restricted Share Unit Award Agreement for Employees under the Third Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 7, 2024)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Third Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 7, 2024)

Form of Global Non-Qualified Share Option Agreement for Employees under the Third Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 7, 2024)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Third Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 7, 2024)

Third Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on June 5, 2024)

Fourth Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on June 5, 2024)

Consulting Agreement, dated January 23, 2024, by and between the Registrant and Thomas Malley (Filed With SEC on May 8, 2024)

Amended Independent Director Compensation Policy (Filed With SEC on March 20, 2024)

Description of the Registrant (Filed With SEC on February 26, 2024)

Consulting Agreement, dated December 7, 2023, by and between the Registrant and Xiaodong Wang (Filed With SEC on February 26, 2024)

First Amendment to the Settlement and Termination Agreement, dated as of January 10, 2024, by and between the Registrant, BeiGene Switzerland GmbH, Bristol-Myers Squibb Company,... (Filed With SEC on February 26, 2024)

Settlement and Termination Agreement, dated as of August 1, 2023, by and between the Registrant, BeiGene Switzerland GmbH, Bristol-Myers Squibb Company, Celgene Corporation,... (Filed With SEC on November 9, 2023)

Mutual Termination and Release Agreement, dated September 17, 2023, by and between BeiGene Switzerland GmbH and Novartis Pharma AG (Filed With SEC on November 9, 2023)

Mutual Termination and Release Agreement, dated July 10, 2023, by and between BeiGene Switzerland GmbH and Novartis Pharma AG (Filed With SEC on August 2, 2023)

Facility Agreement, dated as of July 28, 2023, by and between the Registrant and China Merchants Bank Co., Ltd (Filed With SEC on August 2, 2023)

Offer Letter, dated June 10, 2022, by and between the Registrant and Chan Lee (Filed With SEC on August 2, 2023)

Amended and Restated Employment Apportionment Agreement, dated June 16, 2023, by and between BeiGene (Beijing) Co., Limited, BeiGene Guangzhou Biologics Manufacturing Co., Ltd.,... (Filed With SEC on August 2, 2023)

Form of Global Restricted Share Unit Award Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 2, 2023)

Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 2, 2023)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 2, 2023)

Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 2, 2023)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 2, 2023)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 2, 2023)

Second Amendment to Collaboration Agreement dated (Filed With SEC on May 4, 2023)

Amendment No. 2 to Registration Rights Agreement, dated May 3, 2023, between the Registrant and the Investors (Filed With SEC on May 4, 2023)

Amended Independent Director Compensation Policy (Filed With SEC on March 29, 2023)

Description of (Filed With SEC on February 27, 2023)

Amendment No. 3 to Share Purchase Agreement, dated January 30, 2023, by and between the Registrant and Amgen Inc (Filed With SEC on February 27, 2023)

Form of Global Non-qualified Share Option Agreement for Employees under BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on November 9, 2022)

Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on November 9, 2022)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on November 9, 2022)

First Amendment to Collaboration Agreement dated April 20, 2022, by and between the Registrant and Amgen Inc (Filed With SEC on August 8, 2022)

Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2022)

Form of Global Restricted Share Unit Award Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2022)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2022)

Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2022)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2022)

Form of Global Non-Qualified Share Option Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2022)

Amendment No. 2 to the Second Amended and Restated 2019 Share Option and Incentive Plan (Filed With SEC on June 22, 2022)

Consulting Agreement, effective April 3, 2022, by and between BeiGene USA, Inc. and Jane Huang (Filed With SEC on May 9, 2022)

Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)

Employment Agreement, dated December 30, 2021, by and between BeiGene (Shanghai) Co., Ltd. and Lai Wang (Filed With SEC on February 28, 2022)

BeiGene, Ltd. Independent Director Compensation Policy, as amended (Filed With SEC on February 22, 2022)

U.S. Letter Agreement, dated as of November 30, 2021, by and among the Company and China International Capital Corporation Limited, Goldman Sachs Gao Hua Securities Co. Ltd.,... (Filed With SEC on December 6, 2021)

Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 5, 2021)

Form of Global Restricted Share Unit Award Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 5, 2021)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 5, 2021)

Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 5, 2021)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 5, 2021)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 5, 2021)

Third Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on August 5, 2021)

Offer Letter, dated May 29, 2020, by and between the Registrant and Julia Wang (Filed With SEC on August 5, 2021)

Employment Agreement, dated May 9, 2014, by and between BeiGene (Beijing) Co., Ltd. and Lai Wang (Filed With SEC on August 5, 2021)

Renewed Employment Agreement, dated May 9, 2017, by and between BeiGene (Beijing) Co., Ltd. and Lai Wang (Filed With SEC on August 5, 2021)

Consulting Agreement, dated June 30, 2021, by and between the Registrant and Howard Liang (Filed With SEC on August 5, 2021)

Collaboration and License Agreement, dated January 11, 2021, by and between BeiGene Switzerland GmbH and Novartis Pharma AG (Filed With SEC on May 6, 2021)

BeiGene, Ltd. Independent Director Compensation Policy, as amended (Filed With SEC on April 8, 2021)

Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2021)

Consulting Agreement, dated February 24, 2021, by and between the Registrant and Xiaodong Wang (Filed With SEC on February 25, 2021)

Underwriting Agreement, dated as of December 1, 2020, by and among the Company, the Selling Shareholders and Goldman Sachs & Co. LLC, as the representative of the several... (Filed With SEC on December 2, 2020)

Amendment No. 1 to Registration Rights Agreement, dated December 1, 2020, between the Company and the Investors (Filed With SEC on December 2, 2020)

Restated Amendment No. 2 to Share Purchase Agreement, dated September 2 (Filed With SEC on September 24, 2020)

Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)

Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)

Form of Share Purchase Agreement (Filed With SEC on July 13, 2020)

Amendment No. 1 to the Second Amended and Restated 2019 Share Option and Incentive Plan (Filed With SEC on June 17, 2020)

Employment Apportionment Agreement, dated March 1, 2020, by and between BeiGene (Beijing) Co., Ltd., BeiGene Guangzhou Biologics Manufacturing Co., Ltd. and Xiaobin Wu (Filed With SEC on May 11, 2020)

Independent Director Compensation Policy, as amended (Filed With SEC on May 11, 2020)

Amendment No. 2 to Share Purchase Agreement, dated March 17, 2020, by and between Amgen Inc. and the Company (Filed With SEC on March 17, 2020)

Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2020)

Share Purchase Agreement, dated October 31, 2019, by and between Amgen Inc. and the Registrant (Filed With SEC on March 2, 2020)

Amendment No. 1 to Share Purchase Agreement, dated December 6, 2019, by and between Amgen Inc. and the Registrant (Filed With SEC on March 2, 2020)

Guarantee, dated October 31, 2019, made by and between Amgen Inc. and the Registrant (Filed With SEC on March 2, 2020)

Assignment and Assumption Agreement, dated December 29, 2017, by and between the Registrant and BeiGene Switzerland GmbH (Filed With SEC on March 2, 2020)

Collaboration Agreement, dated October 31, 2019, by and among the Registrant, BeiGene Switzerland GmbH and Amgen Inc (Filed With SEC on March 2, 2020)

Letter Agreement, dated June 14, 2019, by and among the Registrant, BeiGene Switzerland GmbH, Celgene Corporation and Celgene Switzerland LLC, to terminate the Amended and... (Filed With SEC on August 8, 2019)

Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)

Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)

Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)

Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)

BeiGene, Ltd. Independent Director Compensation Policy, as amended (Filed With SEC on June 5, 2019)

Amendment No. 1 to the Second Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on June 5, 2019)

Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on December 12, 2018)

Second Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on December 12, 2018)

Form of Restricted Share Unit Award Agreement for Consultants under the Amended and Restated BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on November 8, 2018)

Amended and Restated BeiGene, Ltd. 2018 Inducement Equity Plan (Filed With SEC on August 13, 2018)

Amended and Restated BeiGene, Ltd. 2018 Employee Share Purchase Plan (Filed With SEC on August 13, 2018)

Amended and Restated BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on August 13, 2018)

Executive Employment Agreement, dated April 28, 2018, by and between BeiGene (Beijing) Co., Ltd. and Xiaobin Wu (Filed With SEC on August 9, 2018)

Form of Restricted Share Unit Award Agreement under the BeiGene, Ltd. 2018 Inducement Equity Plan (Filed With SEC on August 9, 2018)

Forms of Restricted Share Unit Award Agreement and Share Option Agreement under the BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on August 9, 2018)

Consulting Agreement, dated July 24, 2018, by and between the Registrant and Xiaodong Wang (Filed With SEC on August 9, 2018)

International Underwriting Agreement, dated as of August 2, 2018, by and among the Company and the international underwriters named therein (Filed With SEC on August 3, 2018)

Hong Kong Underwriting Agreement, dated as of July 27, 2018, by and among the Company; Morgan Stanley Asia Limited; Goldman Sachs (Asia) L.L.C.; Credit Suisse (Hong Kong) Limited;... (Filed With SEC on August 1, 2018)

BeiGene, Ltd. 2018 Employee Share Purchase Plan (Filed With SEC on June 8, 2018)

BeiGene, Ltd. 2018 Inducement Equity Plan (Filed With SEC on June 8, 2018)

Form of Non-Qualified Share Option Agreement under the BeiGene, Ltd. 2018 Inducement Equity Plan (Filed With SEC on June 8, 2018)

Form of Restricted Share Unit Award Agreement under the BeiGene, Ltd. 2018 Inducement Equity Plan (Filed With SEC on June 8, 2018)

BeiGene, Ltd. Independent Director Compensation Policy, as amended (Filed With SEC on June 8, 2018)

Form of Non-Qualified Share Option Agreement for Non-Employee Directors under the BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on June 8, 2018)

Form of Restricted Share Unit Award Agreement for Non-Employee Directors under the BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on June 8, 2018)

Underwriting Agreement, dated as of January 17, 2018, by and among the Company and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Cowen and Company, LLC and Leerink Partners... (Filed With SEC on January 18, 2018)

Amended and Restated Exclusive License and Collaboration Agreement, dated August 31, 2017, by and among the Registrant, Celgene Corporation and Celgene Switzerland LLC (Filed With SEC on November 13, 2017)

License and Supply Agreement, dated July 5, 2017, by and between the Registrant and Celgene Logistics Srl (Filed With SEC on November 13, 2017)

Amendment No. 1 to BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on November 13, 2017)

Forms of Restricted Share Unit Award Agreement and Share Option Agreement under BeiGene, Ltd. 2016 Share Option and Incentive Plan (Filed With SEC on November 13, 2017)

BeiGene, Ltd. 2,465,000 American Depositary Shares Representing 32,045,000 Ordinary Shares (par value $0.0001 per share) Underwriting Agreement (Filed With SEC on August 11, 2017)

SHARE SUBSCRIPTION AGREEMENT By and Between Celgene Switzerland LLC and BeiGene, Ltd. Dated as of July 5, 2017 (Filed With SEC on July 6, 2017)

FORM BeiGene, Ltd. (Filed With SEC on May 10, 2017)

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [...***...]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on May 10, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on April 26, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 17, 2016)

BeiGene, Ltd. [] American Depositary Shares Representing [] Ordinary Shares (par value $0.0001 per share) Underwriting Agreement (Filed With SEC on November 17, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 10, 2016)

BeiGene, Ltd. (Filed With SEC on August 10, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2016)

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [...***...]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on August 10, 2016)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on May 12, 2016)

BEIGENE, LTD. AND CITIBANK, N.A., As Depositary, AND ALL HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES OUTSTANDING UNDER THE TERMS OF THE DEPOSIT AGREEMENT, DATED AS... (Filed With SEC on April 11, 2016)

DEPOSIT AGREEMENT by and among BEIGENE, LTD. AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of... (Filed With SEC on February 11, 2016)

BeiGene, Ltd. [] American Depositary Shares Representing [] Ordinary Shares (par value $0.0001 per share) Underwriting Agreement (Filed With SEC on February 2, 2016)

NOTE AMENDMENT AND EXCHANGE AGREEMENT (Filed With SEC on January 27, 2016)

AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on January 27, 2016)

DEPOSIT AGREEMENT by and among BEIGENE, LTD. AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of... (Filed With SEC on January 19, 2016)

BEIGENE, LTD. 2016 SHARE OPTION AND INCENTIVE PLAN (Filed With SEC on January 19, 2016)

INDEMNIFICATION AGREEMENT (Filed With SEC on January 19, 2016)

BEIGENE, LTD. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on January 19, 2016)

BEIGENE, LTD. NUMBER INCORPORATED IN THE CAYMAN ISLANDS UNDER THE COMPANIES LAW ORDINARY (AS AMENDED OR REVISED FROM TIME TO TIME) SHARES [certificate no.] [no. of shares] (Filed With SEC on December 9, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on December 9, 2015)

SECOND AMENDMENT AGREEMENT (Filed With SEC on December 9, 2015)

SECOND AMENDED & RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 16, 2015)

BEIGENE, LTD 2011 OPTION PLAN (the Plan) (Filed With SEC on October 16, 2015)

(English translation) HK201102001 Premises Lease Contract (Filed With SEC on October 16, 2015)

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [...***...]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on October 16, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on October 16, 2015)

EMPLOYMENT CONTRACT (FOREIGN EMPLOYEES) (MX) (Filed With SEC on October 16, 2015)

EMPLOYMENT CONTRACT (CHINESE EMPLOYEE) -MX( (Filed With SEC on October 16, 2015)

SENIOR PROMISSORY NOTE (Filed With SEC on October 16, 2015)

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [...***...]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on October 16, 2015)

Category

Industry

Companies

Contracts

BeiGene, Ltd. Contracts & Agreements